Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptation of Blood-stage Controlled Human Malaria Infection for Evaluation of Transmission Blocking Malaria Interventions in Malaria Endemic Countries

NCT06172686 is registered in ClinicalTrials.gov with Ifakara Health Institute as lead sponsor.

NCT NCT06172686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06172686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptation of Blood-stage Controlled Human Malaria Infection for Evaluation of Transmission Blocking Malaria Interventions in Malaria Endemic Countries
Lead sponsor
Ifakara Health Institute
Phase
Phase 1
Overall status
Unknown status
Start date
January 9, 2024
Completion date
June 30, 2024
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

controlled human malaria infection, induced blood stage malaria infection, malaria challenge, malaria transmission